Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis

International Journal of Infectious Diseases - Netherlands
doi 10.1016/j.ijid.2017.10.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rifabutin: Is It Useful in the Treatment of Multidrug-Resistant Tuberculosis?

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Final Treatment Outcomes of Multidrug- And Extensively Drug-Resistant Tuberculosis Patients in Latvia Receiving Delamanid-Containing Regimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-Resistant Mycobacterium Tuberculosis in China

BMC Infectious Diseases
Infectious Diseases
2020English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Impact of Diabetes Mellitus on Treatment Outcome of Multidrug Resistant Pulmonary Tuberculosis

Journal of Evolution of Medical and Dental Sciences
2018English

Shorter Regimens for Multidrug-Resistant Tuberculosis Should Also Be Applicable in Europe

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2009English

Treatment Outcomes of Regimens Containing Delamanid Within Therapy of Multiple and Extensive Drug Resistant Tuberculosis in the Russian Federation

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy